HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Diovan safely and effectively. See full prescribing information for Diovan.
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Diovan HCT safely and effectively. See full prescribing information for
Page 1 of 18 CO-DIOVAN ® Valsartan and hydrochlorothiazide NAME OF THE DRUG Active ingredients: Valsartan, hydrochlorothiazide Co-Diovan is available in five strengths: Co-Diovan 80/12.5, Co-Diovan 160/12.5, Co-Diovan 160/25, Co-Diovan 320/12.5 and Co-Diovan 320/25 .
Diovan ® /Diovan HCT ® Clinical Summary for Formulary Review Please consult complete Prescribing Information Diovan ® (valsartan) is a nonpeptide, orally active and specific angiotensin II antagonist acting on the AT 1 receptor subtype.
Committee to Evaluate Drugs (CED) Recommendations and Reasons This document posted October 2009 Valsartan / Hydrochlorothiazide - new dosage strengths Product: VALSARTAN/HYDROCHLOROTHIAZIDE (Diovan-HCT ® ) 320mg/12.5mg, 320mg/25mg tablets (new dosage strengths) Class of drugs: Anti-hypertensive ...
DIOVAN and DIOVAN HCT . Rx SAMPLE REQUEST FORM Return Completed Form via Fax to: 1-888-697-7607 . Dear Licensed Practitioner: Thank you for requesting samples from Novartis Pharmaceuticals Corporation.
Diovan HCT ® T2006-ProposedMAR Diovan HCT ® valsartan and hydrochlorothiazide, USP Combination Tablets 80 mg/12.5 mg 160 mg/12.5 mg 160 mg/25 mg Rx only Prescribing Information USE IN PREGNANCY When used in pregnancy during the second and third trimesters, drugs that act ...
CO-DIOVAN ® Valsartan/hydrochlorothiazide Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Co-Diovan.
IMPORTANT: PLEASE READ Page 1 of 4 CONSUMER INFORMATION Pr DIOVAN* valsartan Tablets This leaflet is part III of a three-part "Product Monograph" published when DIOVAN* was approved for sale in Canada and is designed specifically for Consumers.
Diovan is associated with a number of serious risks. The PI for Diovan includes a black box warning concerning the risk of injury or death to the developing fetus when used in pregnancy, in addition to warnings and precautions regarding the risks of hypotension and impaired renal function.